# Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief

Study · id `cardio:ct-nct01413841` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01413841](<https://clinicaltrials.gov/study/NCT01413841>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01413841

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

## Technical summary

Registry record NCT01413841. Randomized; triple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT01413841, source copy `cardio:ctgov-nct01413841-2012-08-10`, retrieved 2026-11-18)
- Start date: 2011-07 (registry gives no type) (ClinicalTrials.gov record NCT01413841, source copy `cardio:ctgov-nct01413841-2012-08-10`, retrieved 2026-11-18)
- Primary completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01413841, source copy `cardio:ctgov-nct01413841-2012-08-10`, retrieved 2026-11-18)
- Completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01413841, source copy `cardio:ctgov-nct01413841-2012-08-10`, retrieved 2026-11-18)
- Countries: Sweden (ClinicalTrials.gov record NCT01413841, source copy `cardio:ctgov-nct01413841-2012-08-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01413841-2012-08-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief
- Acronym: OXYPAIN
- Condition: Angina
- Intervention (Drug): Nasal oxygen
- Intervention (Drug): Regular nasal air
- Lead sponsor: Region Skane
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry lists this organization as the lead sponsor: Region Skane (`cardio:org-region-skane`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The analgesic effect of oxygen during percutaneous coronary intervention (the OXYPAIN Trial) (`cardio:pubmed-23957447`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a7305f3a4355f6aff11a076f199d456f402bbbbdbe5bebad8e47caad5bc317e3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
